Literature DB >> 2860688

Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates.

L Stinus, M Winnock, A E Kelley.   

Abstract

In the present study the functional relationship between enkephalinergic and dopaminergic neurones at the level of the nucleus accumbens was investigated. The study consisted of two experiments in which dopaminergic (DA) transmission was chronically inhibited, and the behavioural locomotor response to intra-accumbens opiate injections analysed. First, specific 6-OHDA lesion of the DA-A10 neurones (either in nucleus accumbens or ventral tegmental area) was found markedly to increase the behavioural excitatory effects induced by nucleus accumbens injection of opioid peptides or morphine. Specific lesion of the central noradrenergic neurones had no such effect. Second, chronic pharmacological blockade of DA activity either with reserpine or a neuroleptic (pipothiazine palmitate) similarly induced a strong enhancement of the behavioral response to intra-accumbens opiate injection. The results are discussed in terms of novel mechanisms underlying denervation supersensitivity, and may have important implications for the relation between dopamine dysfunction in mental illness and opiate addiction.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2860688     DOI: 10.1007/bf00428196

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Action of the palmitic ester of pipotiazine on dopamine metabolism in the nigro-striatal, meso-limbic and meso-cortiacal systems.

Authors:  B Scatton; A Boireau; C Garret; J Glowinski; L Julou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-01       Impact factor: 3.000

2.  Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

Authors:  M HOLZBAUER; M VOGT
Journal:  J Neurochem       Date:  1956-05       Impact factor: 5.372

3.  Opiate receptor binding in rhesus monkey brain: association with limbic structures.

Authors:  C C LaMotte; A Snowman; C B Pert; S H Synder
Journal:  Brain Res       Date:  1978-10-27       Impact factor: 3.252

4.  Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs.

Authors:  J S Hong; H Y Yang; W Fratta; E Costa
Journal:  J Pharmacol Exp Ther       Date:  1978-04       Impact factor: 4.030

5.  Determination of methionine enkephalin in discrete regions of rat brain.

Authors:  J S Hong; H Y Yang; W Fratta; E Costa
Journal:  Brain Res       Date:  1977-10-07       Impact factor: 3.252

6.  Stimulant effects of enkephalin microinjection into the dopaminergic A10 area.

Authors:  C L Broekkamp; A G Phillips; A R Cools
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

7.  Effect of chronic treatment with haloperidol on serum prolactin, striatal opiate receptors and beta-endorphin content in rat brain and pituitary.

Authors:  N Kato; K R Shah; H G Friesen; V Havlicek
Journal:  Prog Neuropsychopharmacol       Date:  1981

8.  A topographic localization of enkephalin on the dopamine neurons of the rat substantia nigra and ventral tegmental area demonstrated by combined histofluorescence-immunocytochemistry.

Authors:  R P Johnson; M Sar; W E Stumpf
Journal:  Brain Res       Date:  1980-08-04       Impact factor: 3.252

9.  (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic.

Authors:  C B Pert; A Pert; J K Chang; B T Fong
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

10.  Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference.

Authors:  D van der Kooy; R F Mucha; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

View more
  13 in total

1.  Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.

Authors:  C Schremmer; R Morgenstern; H Fink; T Ott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.

Authors:  Stephan Steidl; David I Wasserman; Charles D Blaha; John S Yeomans
Journal:  Neurosci Biobehav Rev       Date:  2017-09-23       Impact factor: 8.989

3.  Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the Nucleus caudatus but not in the Nucleus accumbens: differential involvement of delta and mu opioid receptors.

Authors:  V Daugé; P Rossignol; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Increased rewarding properties of morphine in dopamine-transporter knockout mice.

Authors:  C Spielewoy; F Gonon; C Roubert; V Fauchey; M Jaber; M G Caron; B P Roques; M Hamon; C Betancur; R Maldonado; B Giros
Journal:  Eur J Neurosci       Date:  2000-05       Impact factor: 3.386

5.  Rewarding and psychomotor stimulant effects of endomorphin-1: anteroposterior differences within the ventral tegmental area and lack of effect in nucleus accumbens.

Authors:  Abraham Zangen; Satoshi Ikemoto; James E Zadina; Roy A Wise
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

6.  Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion.

Authors:  Minoru Narita; Keisuke Mizuo; Hirokazu Mizoguchi; Mamoru Sakata; Michiko Narita; Leon F Tseng; Tsutomu Suzuki
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

7.  Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors.

Authors:  L Churchill; B P Roques; P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

8.  Effects of accumbens DALA microinjections on brain stimulation reward and behavioral activation in intact and 6-OHDA treated rats.

Authors:  P L Johnson; J R Stellar
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

9.  Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity.

Authors:  L Churchill; M A Klitenick; P W Kalivas
Journal:  J Neurosci       Date:  1998-10-01       Impact factor: 6.167

10.  Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.

Authors:  G D Phillips; T W Robbins; B J Everitt
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.